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Neural crest cells (NCCs) are indispensable for the development of the cardiac outflow tract (OFT). Here, we show that mice lacking Smad4 in
NCCs have persistent truncus arteriosus (PTA), severe OFT cushion hypoplasia, defective OFT elongation, and mispositioning of the OFT. Cardiac
NCCs lacking Smad4 have increased apoptosis, apparently due to decreased Msx1/2 expression. This contributes to the reduction of NCCs in the
OFT. Unexpectedly, mutants have MF20-expressing cardiomyocytes in the splanchnic mesoderm within the second heart field (SHF). This may
result from abnormal differentiation or defective recruitment of differentiating SHF cells into OFT. Alterations in Bmp4, Sema3C, and PlexinA2
signals in the mutant OFT, SHF, and NCCs, disrupt the communications among different cell populations. Such disruptions can further affect the
recruitment of NCCs into the OFT mesenchyme, causing severe OFT cushion hypoplasia and OFT septation failure. Furthermore, these NCCs have
drastically reduced levels of Ids and MT1-MMP, affecting the positioning and remodeling of the OFT. Thus, Smad-signaling in cardiac NCCs has
cell autonomous effects on their survival and non-cell autonomous effects on coordinating the movement of multiple cell lineages in the positioning
and the remodeling of the OFT.
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Nearly 1% of live births in humans have congenital heart
diseases (CHDs) with about a third of these CHDs affecting the
outflow tract (OFT) and its derivatives (Thom et al., 2006).
Many of these defects result from abnormalities in the in-
corporation of distinct cellular lineages into the cardiac outflow
tract, which requires precise timing and cell–cell communica-
tions. Cardiac development initiates with progenitor cells in the
two bilaterally regions of the lateral mesoderm, namely the
primary or first heart field (FHF) (Srivastava, 2006). Recent⁎ Corresponding author. Fax: +1 314 362 8237.
E-mail address: fchen@im.wustl.edu (F. Chen).
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doi:10.1016/j.ydbio.2007.08.044studies have provided convincing evidence that a second heart
field (SHF), comprised of cells in pharyngeal and splanchnic
mesoderm anterior and medial to the FHF, contributes myo-
cardium to the OFT and right ventricle (Abu-Issa et al., 2004;
Black, 2007; Eisenberg and Markwald, 2004; Kelly, 2005;
Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001).
The recruitment of the SHF mesoderm into the OFT and right
ventricle requires precise control of gene expression and
interactions among different cell lineages (Black, 2007; Kelly,
2005).
The involvement of cardiac neural crest (CNC), a subgroup
of neural crest cells (NCCs), in OFT development has been well
documented by CNC ablation studies in chick as well as by
genetic studies in mice and other model organisms (Brown and
Baldwin, 2006; Hutson and Kirby, 2007; Stoller and Epstein,
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migrate into the OFT as early as E9.5 in mice (Jiang et al.,
2000), and mediate the remodeling of the OFT into the pulmoõ-
nary trunk and the ascending aorta. NCC ablation or the deletion
of genes in NCCs results in a spectrum of defects, including
pharyngeal arch patterning defects, double outlet of right
ventricle, tetralogy of Fallot, and persistent truncus arteriosus
(PTA) in which the aorticopulmonary septum fails to form
(Brown and Baldwin, 2006; Hutson and Kirby, 2007; Stoller
and Epstein, 2005). In addition, cell ablation studies in chick
have shown that CNC is necessary for the addition of the myo-
cardium from the SHF to the OFT and the caudal movement of
the OFT (Waldo et al., 2001, 2005a; Yelbuz et al., 2002).
Smad transcription factors are at the core of the transcrip-
tional responses in the transforming growth factor β (Tgfβ)
signaling pathway. Tgfβ superfamily members are structurally
related secreted cytokines that include Tgfβ isoforms, activins,
bone morphogenetic proteins (BMPs), and others. The binding
of ligands to their receptors leads to the phosphorylation of the
receptor-regulated Smads (R-Smads). The phosphorylated R-
Smads complex with the common Smad, Smad4, before trans-
locating into the nucleus to regulate the transcription of the
target genes (Massague et al., 2005). Signals from different
Tgfβ ligands and receptors diverge and converge on different
sets of R-Smads, producing distinct and sometimes opposing
outcomes. The Tgfβ pathway is one of the most versatile cyto-
kine signaling pathways in metazoans, regulating biological
processes from cell division to the patterning of the organism
(Massague et al., 2005). Previous studies have shown that a
spectrum of OFT and pharyngeal arch artery (PAA) defects can
result from germline deletions and NCC-specific inactivation of
a number of Tgfβ superfamily ligands and receptors (Choudh-
ary et al., 2006; Gaussin et al., 2005; Kaartinen et al., 2004; Kim
et al., 2001; Ma et al., 2005; Molin et al., 2004; Sanford et al.,
1997; Stottmann et al., 2004; van Wijk et al., 2007; Wang et al.,
2006; Wurdak et al., 2005). Recent advances have revealed that
besides the kinase activities of the Tgfβ type I receptors, other
kinases, such as MAPK, CDK, CamK II, and GRK2, can also
phosphorylate Smads (Massague et al., 2005; Xu, 2006). In
addition, Smad-independent Tgfβ responses have been reported
in Smad-deficient cell lines and animal models (Massague et al.,
2005; Xu, 2006). Signal transduction from Tgfβ ligands and
receptors to Smads is complicated and nonlinear. Thus, to better
understand the mechanism by which NCCs regulate cardiac
development, it is necessary to investigate the precise role of
Smad signaling in this context in addition to the studies of the
Tgfβ ligands and receptors.
In this study, we have found that the absence of Smad4 in
NCCs causes a wide spectrum of OFT defects, including OFT
cushion hypoplasia, OFT septation defect, OFT elongation
defect, and OFT alignment defect. We have observed increased
apoptosis in the mutant cardiac NCCs, suggesting an indispen-
sable cell autonomous role of Smad signaling in NCC survival.
Furthermore, mice with NCCs lacking Smad4 have alterations
in the expression of Bmp4, Sema3C, and PlexinA2 and other
molecules in the OFT myocardium, SHF mesoderm, or NCCs,
reflecting disrupted communications among these cell lineages.These defects lead to disruptions in NCC recruitment to OFT
cushion, contributing to the observed OFT cushion hypoplasia.
We have also observed abnormal presence of MF20-expressing
cardiomyocytes in the splanchnic mesoderm within the SHF
and a concurrent failure in the OFT caudal movement. The
ectopic presence of MF20-expressing cells in the SHF may be a
result of defective recruitment of mesodermal cells from the
SHF to OFT myocardium, or abnormal differentiation due to
the altered signaling between the Smad4-deficient NCCs and
the SHF mesodermal cells. Our data also show that cardiac
NCCs lacking Smad4 have greatly reduced expression of In-
hibitor of differentiation (Id) genes and Membrane type-1
matrix metalloproteinase (MT1-MMP), both of which are cri-
tical for tissue remodeling. Thus the reduction of Ids and MT1-
MMP may provide the basis for the failure of OFT caudal
movement in the mutants that involves extensive tissue remo-
deling. This study reveals both a direct role of Smad signaling
on NCC survival and indirect effects, through communications
with other cell lineages, in orchestrating gene expression and
the integration of multiple cell lineages for the remodeling of
the OFT.
Materials and methods
Mouse (Mus musculus) strains and sample collection
The generation of the floxed-Smad4 allele was described previously (Yang et
al., 2002). Mice carrying this floxed-Smad4 allele were crossed with theWnt1Cre
transgenic mice to produce Wnt1Cre;Smad4floxed/floxed embryos that would have
homozygous deletion of Smad4 in NCCs.Wnt1Cre;Smad4floxed/floxed embryos are
designated as mutants in this study. Their littermates with no homozygous
deletion of Smad4 in any cells are considered controls. To fate map the NCCs,
the Rosa26RLacZ transgene was introduced into the Wnt1Cre;floxed-Smad4
mice. Direct comparison was made between littermates. All experiments were
repeated at least three times.
Histological analysis
For histological analyses, embryos were fixed with 4% paraformaldehyde
and embedded in paraffin. Sections of 7 μm were collected and stained fol-
lowing standard protocol. For immunohistochemistry, sections were stained
with a rabbit polyclonal anti-beta galactosidase antibody (MP Biomedical, 7A6,
1:1000) and a mouse monoclonal anti-MF20 (Developmental study hybridoma
bank, 1:50). Appropriate AlexaFlour488 or 555-conjugated secondary anti-
bodies (Molecular Probe, 1:1000) were used to detect the corresponding primary
antibodies. Whole-mount immunostaining was carried out with an antibody for
Pecam-1 (BD Pharmingen, CD31, 1:50) as described (Graef et al., 2001). 5-
Bromo-4-chloro-3-indolyl-D-galactoside (Xgal) whole-mount staining of
embryos was performed as described (Chang et al., 2004).
Proliferation and apoptosis
BrdU was injected (i.p.) into pregnant mice 1.5 h before embryo harvest and
was detected by a mouse monoclonal anti-BrdU antibody (Developmental study
hybridoma bank, 1:200). Terminal deoxynucleotidyltransferase-mediated dUTP
nick end labeling (TUNEL) analysis was performed on paraffin-embedded
sections by using the ApopTag plus peroxidase in situ apoptosis detection kit
(Roche, Nutley, NJ). Proliferation index is presented as the average number of
BrdU positive cells per 100 cells counted. NCC proliferation index was
determined by counting about 200 NCCs in the PA-OFT region for each sample
(n=6 for each group). About 30–60 cells were counted in distal region of OFT
myocardium in each mouse for OFT myocardium proliferation index (n=9 for
each group). Exactly 30 cells in splanchnic mesoderm caudal to the OFT
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were counted for the calculation of the proliferation index in this particular SHF
region. The proliferation index was calculated individually for each mouse and
Student’s t-test was employed to detect the statistical difference between the
control and mutant groups.
RNA in situ hybridization
Whole-mount RNA in situ hybridization was performed as previously des-
cribed (Chen and Capecchi, 1999). In situ probes for Nkx2.5, Gata4, Sema3C,
Bmp4, and Vegf were synthesized from plasmids kindly provided by various
laboratories (Acknowledgments). In situ probes for Has2, Sox9; Id1-3, Slug,
PlexinA2, Msx1/2, Tbx1, and MT1-MMP were synthesized from T-easy vector
(Qiagen, Valencia, CA) with cloned PCR inserts for different genes prepared by
one step RT-PCR (Invitrogen, Carlsbad, CA). After RNA whole-mount in situ
hybridization and microphotography, the embryos were embedded in paraffin
and sectioned. For RNA in situ hybridization on paraffin sections, a DAKO
Tyramide amplification kit was used following manufacturer’s protocol (Dako,
Carpinteria, CA).
Ink injections and corrosive casting
To analyze vessel patterning, India ink was injected into the left ventricle
with glass needles controlled by a mouth pipette and cleared in 1:2 benzyl
alcohol/benzyl benzoate. Corrosive casting was done with Batson’s plastic
replica and corrosion kit (Polysciences, Warrington, PA). The casting polymers
were prepared immediately before the procedure and injected into the left
ventricle using gauge 30 needles and 0.3 ml tuberculosis-injection syringes.
Gentle pressure was applied to the syringe until the blue casting polymers fill the
vasculature. The tissues were left at 4 °C overnight before being placed in
maceration solution at 50 °C to corrode for 6–8 h.Results
Smad4 deficiency in NCCs results in OFT septation defects and
cushion hypoplasia
To study the role of Smad signaling in NCCs during cardiac
development and to avoid the early gastrulation arrest found in
Smad4 null animals, we use the Wnt1Cre transgene (Stottmann
et al., 2004) to mediate the recombination of a loxP-flanked
Smad4 allele (Yang et al., 2002) specifically in NCCs. Embryos
with homozygous deletion of Smad4 in NCCs (Wnt1Cre/+;
Smad4loxP/loxP) are described as mutants in this study. Litter-
mates without homozygous deletion of Smad4 in NCCs have no
phenotype and are described as controls. Except for the heart
and the pharyngeal arch (PA) area, the overt morphology of the
mutants appeared relatively normal up to E11.5 (Figs. 1A–D).
Importantly, retrograde blood flow was observed in the mutant
OFT at E11.5, indicating that the deletion of Smad4 in NCCs
leads to severe cardiac OFT defects (data not shown) (Conway
et al., 2003). While all E11.5 mutants recovered were alive, all
mutant embryos died at E12.5 without exception (Figs. 1E, F).
Mutant embryos were recovered at Mendelian ratio (25% from
compound heterozygous intercross) at different developmental
stages up to E12.5 (Fig. 1G). At E11.5, the mutant embryos
exhibited hypoplasia of the pharyngeal arches (Figs. 1H, I). At
this time, the single OFT was normally in the process of
septating into two distinct channels: the ascending aorta and the
pulmonary trunk (Fig. 1J). The mutant OFT, however, failed to
septate and was connected to the aortic sac as a single tube,resembling PTA in humans (Fig. 1K). The failure of OFT
septation is also evident in the cardiac casting (Figs. 1L, M). In
addition, the OFT cushion was hypoplastic in the mutants at
E11.5, particularly in its distal portion, as shown by the H&E
stained sections (Figs. 1N, O) and sections immunostained with
antibodies against Pecam-1 (labeling endocardium) and MF20
(labeling myocardium) (Figs. 1P, Q). The OFT cushion hypo-
plasia may be a primary defect due to the Smad4 deficiency in
the NCCs and the reduction of NCC contribution to the OFT
(discussed in later sections). However, hemodynamic changes
caused by other cardiac structural defects could cause or con-
tribute to the OFT cushion defects (Bartman and Hove, 2005;
Butcher and Markwald, 2007). Nevertheless, severe OFT
cushion hypoplasia is likely the major cause of the observed
regurgitation at E11.5 with subsequent embryonic death at
E12.5. The thickness and trabeculation of the ventricular myo-
cardium were similar between control and mutant samples at
E10.5 (control, n=22; mutant, n=22). The thickness, but not
the level of trabeculation, of the right ventricular wall was
slightly reduced in all E11.5 mutants examined (control, n=4;
mutant, n=4) (Figs. 1P, Q and data not shown). The subtle
reduction of right ventricular wall thickness in older mutant
embryos may be an accumulative effect of defective myo-
cardium accruement or as a result of hemodynamic changes
due to defects in other cardiac structures, most noticeably the
OFT.
NCC-specific inactivation of Smad4 leads to reduced NCC
contribution to the OFT and disruption in the formation of the
OFT cushion mesenchyme
To study the migration of NCCs and OFT cushion deve-
lopment, we analyzed the migration of NCCs in Wnt1Cre-Ro-
sa26RLacZ mice by whole-mount β-galactosidase staining and
examined the expression of genes involved in cushion
development. At E9.5, a significant number of NCCs had
arrived in the distal OFT (away from the right ventricle) in both
the control and mutant (Figs. 2A–F). At E10.5, when NCCs had
normally reached the proximal OFT (close to the right
ventricle), the NCCs in the mutant embryos only populated
the distal part of the OFTwithout penetrating the proximal OFT.
The decreased penetration and the shorter length of the mutant
OFTs led to a significant reduction of the total number of NCCs
in the OFT of the mutant embryos (Figs. 2G–L). This reduction
of NCC contribution to the OFT was not due to a gross
developmental delay or a cell autonomous migration defect in
NCCs given that the control and mutant were morphologically
comparable at this stage and the migration of NCCs to the dorsal
root ganglia was not affected in mutants (Figs. 2A, B, G, H and
data on Neurofilament staining not shown). The seemingly
unaffected formation of the dorsal root ganglia and the severe
OFT malformations suggest that the development of the OFT is
more sensitive to the absence of Smad signaling in NCCs. This
sensitivity may arise from the requirement of precise commu-
nications among diverse cell lineages during OFT development
that would entail both cell autonomous and non-cell autono-
mous effects of Smad signaling in NCCs.
Fig. 1. Smad4 deficiency in NCCs results in abnormal OFT septation and severe OFT cushion hypoplasia. (A–D) From E9.5 to E11.5, except for OFT defects and PA
hypoplasia at E11.5, no other morphological difference was overtly apparent betweenWnt1Cre;Smad4loxP/loxPmice (MT) and their littermate controls (CT) that do not
have homozygous deletion of Smad4 in NCCs. (E, F) Mutant mice died at E12.5. (G) Mutant embryos were recovered at Mendelian ratio (25% from compound
heterozygotes intercross) at different developmental stages up to E12.5. All mutants died at E12.5 as evidenced by the absence of heart beat (Red). Scar bar: 1 mm. (H,
I) PA hypoplasia was observed in mutants at E11.5. Scar bar: 1 mm. (J, K) At E11.5, the OFT has developed into pulmonary trunk (PT) and ascending aorta (AO) in the
control, while the OFTof the mutant was still not divided. (L, M) Casting experiments revealed two separated outlet channels in the OFT from the control but only one
common outlet in the mutant. (N, O) Hematoxylin and eosin (H&E) staining of sagittal sections at E11.5 showed severe OFT cushion (CU) hypoplasia and persistent
truncus arteriosus (PTA) in mutant compared to the control. (P, Q) MF20 staining (green) and Pecam staining (red) of frontal section at E11.5 revealed a thinner layer of
cushion in mutant OFT compared to the control.
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in the mutants, we examined the expression of Has2 and Sox9,
two important molecules expressed in cushion mesenchymal
cells (Person et al., 2005). Has2 is essential for the biosyn-
thesis of hyaluronan in the cardiac jelly within the cushions
and Has2 null mice fail to undergo epithelial-mesenchymal
transformation (EMT) (Camenisch et al., 2000). On the other
hand, Sox9 is activated when endocardial cells transform into
mesenchymal cells. Mice deficient for Sox9 die from heart
failure with hyperplasia of both the OFT and AV cushions
(Akiyama et al., 2004). By whole-mount RNA in situ hybrid-
ization, we found that expression of Has2 was abolished in the
mutant OFT cushion (Figs. 2M–P). In contrast, Has2 expres-
sion in the atrioventricular (AV) cushion had no significant
change (Figs. 2O, P). In addition, the expression of Sox9 was
greatly reduced in the OFT cushion and in the NCCs in closeapposition to the SHF, but not in the AV cushion in mutant
mice (Figs. 2Q–T). These findings are consistent with previous
observations that NCC defects specifically affect OFT cushion
but not the AV cushion (de Lange et al., 2004; Stoller and
Epstein, 2005). The drastic reduction of Has2 and Sox9 in the
OFT cushion may further affect the OFT cushion development.
Smad4-deficient NCCs have reduced Msx1/2 expression and a
higher apoptotic rate that may contribute to the reduction of
NCCs in the developing cardiac OFT
To study whether potential changes in proliferation and cell
death of NCCs lacking Smad4 contributed to the reduction of
NCCs in the developing OFT, we used BrdU labeling and
TUNEL assays to examine the proliferation and apoptosis of the
NCCs (Figs. 3A–G). NCCs were visualized by an anti-β-
Fig. 2. Smad4 deficiency in NCCs caused a reduction of NCC contribution to the OFT cushion mesenchyme. (A–K) Whole-mount β-galactosidase assay. (A, B) At
E9.5, overall neural crest development is similar between control and mutant, except for the OFT area. (C–F) There is a small reduction of NCCs at proximal OFT
(close to the right ventricle) in the mutant compared to the control at E9.5. (C, D) left side; (E, F) right side. (G, H) At E10.5, NCC population in the PA area is reduced
in the mutant when compared to the control. (I, L) The number of NCCs in OFT in the proximal OFT is significantly reduced. The length of the OFT in the mutants is
shorter compared to the control. (M, N) Has2 whole mount in situ hybridization revealed the lack of Has2 in OFT. (O, P) Paraffin section after whole-mount RNA in
situ showed reduced Has2 expression in OFT cushion. An insert in panel O showed Has2 expression in cushion of atria ventricular canal (AVC). (Q, R) Whole-mount
RNA in situ hybridization showed that Sox9 was ablated in OFT. (S, T) Paraffin section after whole-mount RNA in situ hybridization indicated that Sox9 was down-
regulated both in outflow cushion and in NCCs in apposition to SHF in mutant compared to the controls.
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transgene in these mice. We found no significant difference in
the proliferation index of NCCs between control and mutant
samples (Figs. 3A, B, G) at E10.5. However, TUNEL assay
revealed a marked increase in the number of apoptotic NCCs in
the pharyngeal arches and OFT area in mutant embryos
compared with their controls (Figs. 3C, D). Immunostaining
for β-galactosidase on adjacent sections revealed that most, but
not all, of the apoptotic cells were NCCs (Figs. 3E, F). At E10.5,
the intensity and the domain of expression of both Msx1 and
Msx2 in the PA area were significantly reduced (Figs. 3H–O).
This is consistent with previous finding that Msx1/2 are targets
of Tgfβ superfamily signaling and are required for NCC sur-
vival (Ishii et al., 2005; Tribulo et al., 2003). Thus, our data
suggest that the loss of Smad4 function in NCCs results in
drastically reduced Msx1/2 expression in these cells, leading to
increased apoptosis. The higher apoptotic rate contributes to the
reduction of total NCCs in the pharynx and the OFT area. Thisreduction of NCCs will also inevitably disrupt the precise
cellular interactions and signaling required for the correct mor-
phogenetic remodeling of the OFT.
Mice with NCC-specific inactivation of Smad4 have abnormal
presence of MF20 positive cardiomyocytes within the SHF
To assess how NCCs may influence the SHF cells and OFT
remodeling, we examined the differentiation of SHF cells and
the accruement of the cardiomyocytes from SHF to the elong-
ating OFT. The NCCs were identified by an anti-β-galac-
tosidase antibody in mice carrying both the Wnt1Cre and the
Rosa26RLacZ transgenes. NCCs were located in direct
apposition to SHF cells and in close proximity to myocardial
cells in the OFT (Figs. 4A–D). At E10.5, cells in the SHF do not
express MF20, a cardiomyocyte marker, in the controls (Figs.
4A, C). However, cells in the SHF of the mutant surprisingly
expressed MF20 at E10.5 before they reached the OFT (Figs.
Fig. 3. Smad4-deficient NCCs have reducedMsx1/2 expression and a higher apoptotic rate. (A, B) BrdU labeling showed similar proliferation index between control
and mutant. (C, D) TUNEL assay showed an increased apoptotic rate in PA mesenchyme in mutant compared to the control. (E, F) Immunofluoresence staining
revealed the β-galactosidase positive cells (NCCs) in PA mesenchyme. (G) No difference (p=0.94) was detected in the proliferation rate of NCCs in the PA-OFT
region in control (48±7%) and in mutant (45±7%); values are means±SEM, n=6. (H–O) RNAwhole-mount in situ hybridization indicated that the expression of
bothMsx1 andMsx2was down-regulated in the PA-OFTarea in the mutant. Panels J, K, N, and O are higher magnification views of the PA-OFTarea in panels H, I, L,
and M, respectively.
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sion and some degree of differentiation in SHF at E8.5 (Prall et
al., 2007). To ensure that the difference in MF20 expression in
the splanchnic mesoderm caudal to OFT is truly associated
with Smad4 deficiency in NCCs but not due to experimental
variations, additional pairs of control and mutant samples were
examined. We sectioned a total of 13 mutants and 13 littermate
controls at E10.5. The MF20-expressing cells were present inthe splanchnic mesoderm caudal to the OFT in every mutant
examined and were absent in all the controls at E10.5. The
abnormal presence of MF20 positive cells in this area suggests
defective recruitment of these cells into the OFT (resulting in
the shorter OFT) or abnormal differentiation due to the defect-
ive communication between these mesodermal cells and adja-
cent NCCs lacking Smad4. We further studied the proliferation
of the cells in the splanchnic mesoderm caudal to OFT and the
Fig. 4. Abnormal presence of MF20 positive cardiomyocytes within the SHF. (A, C) Double immunostaining with anti-MF20 (green) and anti-β-galactosidase (red)
antibodies revealed that MF20 was expressed in OFT myocardium but not in the SHF in the control. (B, D) However, MF20 was expressed both in the OFT
myocardium and in the SHF mesoderm in the mutant (arrows). (E, F) BrdU labeling revealed no difference (p=0.38) in the proliferation rate of the OFT myocardium
between control (23±7%) and mutant (23±11%); values are means±SEM, n=9 (G); and a significant reduction (p=2.47E-07) in the proliferation rate in the
splanchnic mesoderm caudal to the OFT between mutant (17±7%) and control (60±8%); * stands for statistical significant difference compared to the control. Values
are means±SEM, n=9 (H).
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F). We found no difference in the proliferation rate of cardio-
myocytes in OFT myocardium between control and mutant
samples (Figs. 4E–G). However, the proliferation rate of the
SHF mesodermal cells caudal to the OFT in the mutant was
significantly lower than those in the controls (Figs. 4E, F, H).
The lower proliferation rate may reflect that these cells are
differentiating into cardiomyocytes.
Inactivation of Smad4 in NCCs impairs the caudal movement
and the elongation of the OFT
To understand the mechanism by which inactivation of
Smad4 in NCCs caused the observed cardiac anomalies, we set
out to investigate the morphogenetic processes during OFT re-
modeling in the mutants. Whole-mount Pecam staining revealed
that the connection of the OFT to the aortic sac was similar
between the mutant and control at E9.5. The junction was
slightly caudal to the second PA artery (PAA2) (Figs. 5A, B). At
E10.5, PAA2 disappeared and the more caudal PAAs emerged.
The connection of the OFT had shifted caudally to near the level
of PAA4 at E10.5 in the controls, as revealed by Indian ink
injection outlining the OFT and PAAs (Figs. 5C, E). The mutant
OFT, however, failed to move caudally and the OFT junction
remained at a level rostral to PAA3 near the level where the
disappeared PAA2 would have been (Figs. 5D, F). Along with
the failed OFT caudal movement, there was a significant de-
crease of OFT length in the mutants (Fig. 5D). As a result of the
failure in caudal movement and elongation of the OFT, the
mutant hearts were located in a more cranial position than thatof the controls (Figs. 5C–F). The level of the OFT along the
anterior–posterior axis did not change significantly from E10.5
to E11.5 in either the controls or the mutants. Further OFT
remodeling, most noticeably septation, occurred only in the
controls but not in the mutants at E11.5 (Figs. 5G–H). A
summary of the level of OFT relative to the PAAs is provided in
Fig. 5I.
Absence of Smad4 in NCCs disrupts the communications
among myocardium, NCCs, SHF mesoderm, and other cell
types during OFT development
Multiple signal molecules, including BMPs, Sema3 isoforms,
and PlexinA2, are involved in the reciprocal signaling between
NCCs and myocardial cells in the OFT. These interactions are
essential for the migration of NCCs into the OFTand the normal
development of the OFT cushion (Brown and Baldwin, 2006;
Hutson and Kirby, 2007; Karafiat et al., 2005; Lepore et al.,
2006; Stoller and Epstein, 2005). To understand the mechanisms
of OFT remodeling defects in the mutants, we examined the
expression of these factors by RNA in situ hybridization in the
control and mutants at E10.5. We have observed alterations in
the expression of Bmp4 in the OFT myocardium and the
splanchnic mesoderm within the SHF in the mutants (Figs. 6A–
D). Furthermore, we examined the transcript levels of Sema3A,
F, and C and PlexinA2 at E10.5 by whole-mount and section
RNA in situ hybridization. We found that, among the Sema3
isoforms, only the expression of Sema3C was significantly
decreased in the OFT myocardium and in the SHF mesodermal
cells of the mutants (Figs. 6E–H, and data not shown). PlexinA2
Fig. 5. Inactivation of Smad4 in NCCs impaired the caudal movement and the
elongation of the OFT. (A, B) Pecam whole-mount immunostaining revealed a
shorter OFT (black arrows) at E9.5. The OFT attachment site to the ventral
pharynx was at the level of PAA2 in both control and mutant (C, D) At E10.5,
India ink injection also outlined a shortened OFT in the mutant compared to the
control. The OFT attachment site to the ventral pharynx was located at the level
caudal to PAA3 (and near PAA4) in the control, but at a position rostral to PAA3
in the mutant (near where the disappeared PAA2 should have been). (E, F)
Ventral view of PAAs showed the rostral OFT attachment site in the mutant at
E10.5. Triangle points to OFT attachment site to ventral pharynx. (G, H) At
E11.5, the wild type OFT was separated into ascending aorta (AO) and
pulmonary trunk (PT) which connected pharyngeal arch 4 and 6, respectively,
while the mutant OFT still connected the heart to the aortic sac as a single
outlet. (I) A summary of the level of OFT attachment relative to PAAs at E9.5
and E10.5.
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reduced in NCCs in areas from the PA region to the OFT (Figs.
6I–L). The expression changes in Bmp4, Sema3C, and Plex-
inA2 reflect the altered cell–cell signaling caused by the absence
of Smad4 in the NCCs. These expression changes, in turn, may
further affect NCC recruitment to OFT cushion and SHF
mesoderm contribution to the OFT myocardium.Smad4 deficiency in NCCs causes reduced expression of the Id
genes and MT1-MMP that are important for extracellular
matrix remodeling
The remodeling of the cardiac OFT involves the restructur-
ing of multiple tissues, including the vasculature. As in the
remodeling of many other structures, degradation and reorga-
nization of extracellular matrix (ECM) precede the actual cell
movement. To study if there was any misregulation of
molecules in the remodeling of the cardiac OFT in mutants,
we examined the expression of several genes known to regulate
vascular or ECM remodeling. We found that the expression of
Vegf, essential for vascular remodeling, had no significant
difference between the control and mutant (data not shown). We
also examined the expression of Ids that have been indicated as
targets of Tgfβ signaling (Sakurai et al., 2004; ten Dijke et al.,
2003) and as important factors in tissue remodeling (Benezra,
2001). By RNA in situ hybridization, we found that Id1 mRNA
had wide spread expression in endocardium, myocardium, OFT
cushion mesenchyme, and the PA areas (Figs. 7A, C). In the
mutants, the expression of Id1 was abolished in the PA area and
in the OFT cushion mesenchyme where normally a large
number of NCCs reside (Figs. 7B, D). The expression of Id1
persisted in the endocardium and myocardium in the mutant
(Figs. 7B, D). The expression domain of Id3 in this region was
similar to that of Id1 except for the myocardium where Id3
expression was considerably less prominent (Figs. 7E, G).
Similar to Id1, expression of Id3 in the mutant was also
selectively decreased in NCCs within PAs and within the OFT
cushion, but not in the adjacent tissues (Figs. 7F, H). Id2
expression level was also down regulated in PAs in mutants,
though its normal expression level was much lower compared to
Id1/3 (data not shown). The reduced level of the Ids may impair
the expression of surface proteinases that are critical for the
remodeling of the ECM during the collective migration of
vascular endothelium and the associated tissues (Fong et al.,
2003; Nieborowska-Skorska et al., 2006; Sakurai et al., 2004).
To test this possibility, we examined the mRNA level of MT1-
MMP (membrane type1 matrix metalloproteinase), one of the
most important surface proteinases for ECM remodeling.
Indeed, MT1-MMP mRNA was significantly reduced in NCCs
populating the pharyngeal area and the OFT compared to the
control at E10 (Figs. 7I–L). Thus, the reduction of Ids and
MT1-MMP in NCCs may affect the normal extracellular matrix
remodeling and OFT caudal movement.
Discussion
In this study, we have shown that Smad4 deficiency in
NCCs causes a range of severe morphogenetic defects in the
cardiac OFT, resulting in valvular regurgitation and subsequent
uniform embryonic lethality at E12.5. While the valvular
regurgitation is most likely caused by the severe OFT cushion
hypoplasia, OFT septation and elongation defects are also
observed in all mutants. The spectrum of cardiac defects
caused by Smad4 deficiency in NCCs resembles those asso-
ciated with cardiac NCC (CNCC) ablation in avian embryos
Fig. 6. Defective OFT myocardial accruement of SHF mesodermal cells disrupts the normal distribution of signaling molecules essential for NCCs migration. (A, B)
Whole-mount RNA in situ hybridization revealed a reduction in Bmp4 expression in OFT. (C, D) Close examination of the subsequent sections further revealed that
the reduction of Bmp4 expression is in OFT myocardium. (E, F) Whole-mount in situ hybridization reveals a marked reduction in Sema3C in OFT cuff in mutant
compared to the control. (G, H) RNA in situ hybridization on paraffin section showed that the Sema3C was mainly expressed in outflow tract myocardium and was
significantly down-regulated in mutants compared to the controls. (I, J) RNA in situ hybridization on paraffin section reveals a lower level of PlexinA2 transcripts in
PA mesenchyme cells. Panels K and L are higher magnification views of PA region in panels I and J. Triangle points to the splanchnic mesoderm within the SHF.
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signaling within NCCs for cardiac development. Our data
suggest that both the reduction of the number of CNCCs andFig. 7. Smad4 deficiency in NCCs causes reduced expression of Id genes and M
hybridization on paraffin section reviewed a significant reduction of Id1 expression bo
D are higher magnification views of the rectangular regions in panels A and B. (E–H)
Id3 expression both in PAmesenchyme and OFTmesenchyme at E10.5. Panels G and
L) RNA in situ hybridization on paraffin section showed thatMT1-MMP was down-r
controls. Panels K and L are higher magnification views of the rectangular regions
splanchnic mesoderm within the SHF.the inability of the remaining CNCCs to express key regu-
latory genes lead to the defective remodeling of the cardiac
OFT.T1-MMP important for extracellular matrix remodeling. (A–D) RNA In situ
th in PAmesenchyme cells and in OFTmesenchyme cells at E10.5. Panels C and
RNA in situ hybridization on paraffin section reviewed a significant reduction of
H are higher magnification views of the rectangular regions in panels E and F. (I–
egulated in PA mesenchyme and in OFT at E10.5 in the mutants compared to the
in panels I and J. EN: endothelia; MYO: myocardium. Triangles point to the
181Q. Jia et al. / Developmental Biology 311 (2007) 172–184Smad4 is in a key position in the Tgfβ superfamily signaling
network in NCCs for the normal development of the cardiac
OFT
Although NCC-specific inactivation of Tgfβ superfamily
receptors commonly leads to OFT septum defect and PTA, only
theWnt1Cre; Bmpr1aflox/null (Stottmann et al., 2004) model has
embryonic lethality in mid gestation similar to the Wnt1Cre;
Smad4flox/flox mutants in this study. The migration of NCCs to
OFT is impaired in mice with NCC-specific inactivation of Alk2
(Kaartinen et al., 2004). Forty percent of these mice died
between E14 and E18, while the rest survive until birth.
However, similar reduction of NCCs in the OFT was not
observed in mutants with NCC-specific inactivation of TgfβR1
or Tgfβr2 (Choudhary et al., 2006; Kaartinen et al., 2004; Wang
et al., 2006; Wurdak et al., 2005), all of which can survive to
birth. On one hand, these observations appear to confirm that
the severity of the defects correlates with the degree of reduction
in the number of CNCCs. On the other hand, the presence of
defects in the OFT in mice lacking obvious changes in the
number of CNCCs may suggest that qualitative changes in the
CNCCs are equally important for the correct patterning of the
OFTand pharyngeal structures. The OFTcushion defect in mice
lacking Smad4 in NCCs is among the most severe in the models
mentioned above. Since Smad4 is at the converging point of
transcriptional responses from different types of Tgfβ super-
family ligands and receptors, the phenotypes we observed in
mice with NCCs lacking Smad4 would, to some degree, reflect
the combined effects of the loss of transcriptional responses
from both Tgfβ signaling and Bmp signaling. Since, as des-
cribed above, the inactivation of receptors specific for Bmp
signaling in NCCs appears to lead to more severe phenotypes in
the development of the OFT than those specifically associated
with the inactivation of Tgfβ signaling, it is likely that Bmp
signaling may have a more important role in these processes.
We have shown that inactivating Smad4 in NCCs inhibits the
expression of the Id genes (Fig. 7). This further supports a more
important role for Bmp signaling in the observed phenotypes
since Bmp signals have been shown to induce the expression of
the Id genes while Tgfβ signaling has the opposite effect
(Kowanetz et al., 2004; ten Dijke et al., 2003).
Absence of Smad4 in NCCs results in abnormal presence of
cardiomyocytes in SHF
The observation of the ectopic presence of MF20-expressing
cells in the splanchnic mesoderm within the SHF caudal to the
OFT is very interesting and may have a number of possible
explanations. First, a signal from the NCCs may normally
suppress the differentiation of splanchnic mesodermal cells into
cardiomyocytes until they migrate into the OFT. Such a signal
may be missing in the Smad4-deficient NCCs, leading to the
premature expression of myocardium marker in the splanchnic
mesoderm. Second, the Smad4-deficient NCCs may send an
abnormal signal to the SHF mesodermal cells that promote
premature myocardium differentiation. In fact, from E9.5 on-
ward, NCCs are in close contact with the splanchnic meso-dermal cells within the SHF. This close contact is the basis of
the intimate signaling communication proposed in the first two
possibilities. The third possibility is that these MF20-expressing
cells may be normally differentiating cells programmed to enter
the OFT from the SHF, but are “stranded” due to a failure in the
accruement of these cells into the OFT myocardium. This ac-
cruement problem can be a result of defective migrating ability
in SHF cells, alteration in cell migration cues along the mig-
ratory path, or the failure of OFT caudal movement. The latter
possibility arises from the fact that MF20 positive cells within
the SHF are located in an area that would normally be added to
the OFT myocardium when the OFT migrates caudally across
the splanchnic mesoderm within the SHF (Waldo et al., 2001,
2005b). It is possible that during normal development, the
caudally migrating OFT recruits the SHF mesodermal cells as
they are differentiating into MF20-expressing cardiomyocytes.
The well orchestrated temporal sequence of the OFT caudal
movement/elongation and the differentiation of the SHF meso-
dermal cells ensures that no MF20-expressing cells are present
in the SHF. In this model, Smad4 deficiency in NCCs leads to a
cascade of events, causing a failure in OFT caudal movement/
elongation and, possibly, the subsequent retention of MF20-
expressing cells in the SHF. Lastly, accumulating evidence
suggests that mechanical forces regulate many aspects of car-
diac development, including gene expression, cellular differ-
entiation, cell movement, and structural remodeling (Bartman
and Hove, 2005; Butcher and Markwald, 2007). Thus, it is also
possible that the observed ectopic presence of MF20-expressing
cells is secondary to hemodynamic changes caused by primary
defects in other cardiac structures. More studies are needed to
further distinguish these possibilities.
Smad signaling in NCCs may regulate OFT development
through its effects on genes important for tissue remodeling
OFT development involves the remodeling of the vascu-
lature and the migration of the endothelial/endocardial cells
along with other cells. Our studies suggest that Smad signaling
in NCCs is essential for the caudal movement of the OFT
through the regulation of the expression of genes required for
the remodeling of vasculature and the reorganization of the
ECM. These genes include the Id gene family and the MMPs.
The Id family of helix–loop–helix transcription factors have
indispensable in vivo roles in angiogenesis and tissue remodel-
ing (Abe, 2006). We have detected a drastic reduction of the
expression of Id1 and Id3 in the NCCs in the pharyngeal area
along the OFT movement route at as early as E9.5 (Fig. 7 and
data not shown). This reduction of Id expression is caused by
Smad4 inactivation in NCCs since Ids are recognized targets
of Bmp signaling (Miyazono and Miyazawa, 2002). Previous
studies have shown that mice lacking both Id1/Id3 die before
E13.5 with vascular malformation in multiple organs, unde-
tectable levels of αVβ3-intergrin and some MMPs, as well
as obvious ECM deposition (Lyden et al., 1999). MT1-MMP,
a surface proteinase induced by Ids (Fong et al., 2003;
Nieborowska-Skorska et al., 2006; Sakurai et al., 2004), is
also critical in preparing the migratory path within extracellular
182 Q. Jia et al. / Developmental Biology 311 (2007) 172–184matrix during cell migration (van Hinsbergh et al., 2006). Con-
sistent with the Id1/Id3 inactivation studies, we also detected a
significant reduction of MT1-MMP in NCCs (Fig. 7) and con-
siderable deposition of ECM along the path of OFT caudal
movement in the mutant (data not shown). The reduced expres-
sion of both Ids and MMPs in NCCs along the route of OFT
caudal movement would impede OFT caudal migration by
increasing ECM deposition. While only the reduction of MT1-
MMP is presented here, based on previous studies by other
laboratories, the reduction of other MMPs in the NCCs deficient
for Smad4 is likely. This may explain the more severe em-
bryonic defects, especially in OFT remodeling, in mice
lacking Smad4 in NCCs than defects found in mice lacking
MT1-MMP alone (Maxwell et al., 1996), which die only after
birth.
Both increased apoptosis and disrupted communications
between NCCs and myocardium may be responsible for the
reduced NCC contribution to the OFT cushion mesenchyme
It has been suggested before that the number of available
CNCCs is critical for the normal cardiac development (van den
Hoff and Moorman, 2000). The requirement of sufficient
number of NCCs may derive from the need for building
materials, for providing appropriate signals, or for shielding off
certain interfering signals (Brown and Baldwin, 2006; Hutson
and Kirby, 2007; Stoller and Epstein, 2005; van den Hoff and
Moorman, 2000). We have observed a significant reduction of
the total number of NCCs in the OFT cushion mesenchyme
from E10.5 onward in the mutants. This reduction contributes to
the observed OFT cushion hypoplasia, OFT septation defect,
and the valvular regurgitation. Our data suggest that this reduct-
ion of NCCs in the OFT may be due to both a cell autonomous
effect of the absence of Smad4 in NCCs for their own survival
and an indirect effect through the defective communications
between NCCs and other cell types, especially the OFT myo-
cardium. The direct effect of the absence of Smad4 on NCC
survival is likely mediated by the reduced expression of both
Msx1 and Msx2 (Fig. 3) and slug (data not shown), all of
which are known to be essential for cell survival (Inukai et al.,
1999; Ishii et al., 2005). On the other hand, the defective cell–
cell communication is more complicated and is likely the result
of defects in a number of interconnected morphogenetic events.
The expression changes in Bmp4, Sema3C, and PlexinA2
reflect the altered cell–cell signaling caused by the absence of
Smad4 in the NCCs. The altered signaling among OFT myocar-
dium, SHF, and NCCs, in turn, could cause further disruptions
in NCC recruitment to OFT cushion, resulting in the observed
OFT cushion hypoplasia.
In summary, this study shows that Smad signaling in NCCs
coordinates the interactions of various signaling molecules and
pathways in multiple cell populations during OFT development.
Smad-signaling in cardiac NCCs has cell autonomous effects
for their survival and non-cell autonomous effects on the pro-
liferation/differentiation/migration of other cell lineages, most
noticeably the SHF mesodermal cells, for the correct position-
ing and remodeling of the OFT.Acknowledgments
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